
    
      This is a dual-center, evaluator-blinded, randomized phase 1 study evaluating skin irritation
      and skin sensitization of HP-1050 transdermal system in comparison to XULANE patch in healthy
      female volunteers. The study will consist of a 4-week Screening Phase and a Treatment Phase.
      The Treatment Phase will consist of the following periods: an Induction Period, a Rest Period
      followed by a Challenge Period and if needed, a Re-Challenge Period.
    
  